Literature DB >> 12439538

Cost analysis of myomectomy, hysterectomy, and uterine artery embolization.

Haya Al-Fozan1, Joanne Dufort, Marilyn Kaplow, David Valenti, Togas Tulandi.   

Abstract

OBJECTIVE: The purpose of this study was to compare inpatient hospital costs of different treatments of uterine fibroid tumors, including myomectomy, hysterectomy, and uterine artery embolization in a teaching hospital. STUDY
DESIGN: We reviewed the hospital database of 545 women with uterine fibroid tumors who were treated with abdominal myomectomy, total abdominal hysterectomy, vaginal hysterectomy, and uterine artery embolization between April 1997 and October 2001.
RESULTS: Women who underwent hysterectomies and uterine artery embolization were significantly older than the women who underwent myomectomy. Uterine artery embolization was associated with the shortest hospital stay, although the hospital stay in the vaginal hysterectomy group was shorter than in the abdominal myomectomy and the total abdominal hysterectomy groups. Compared with other groups, the inpatient cost of nursing in the uterine artery embolization group was the lowest. The total inpatient cost of uterine artery embolization ($1,007.44 +/- $60.65 [Canadian dollars]) was significantly lower than the cost of total abdominal hysterectomy ($1,933.37 +/- $47.68 [Canadian dollars]), abdominal myomectomy ($1,781.73 +/- $47.16 [Canadian dollars]), and vaginal hysterectomy ($1,515.39 +/- $66.72 [Canadian dollars]; P <.001). Sixteen of the 85 patients (18.8%) were hospitalized after uterine artery embolization, mainly for abdominal pain.
CONCLUSION: Compared with abdominal myomectomy, abdominal hysterectomy, and vaginal hysterectomy, uterine artery embolization is associated with a lower hospital cost and a shorter hospital stay. Hospitalization after uterine artery embolization is mainly for abdominal pain after the procedure. A better method of pain control to reduce the rate of hospitalization and its cost is needed.

Entities:  

Mesh:

Year:  2002        PMID: 12439538     DOI: 10.1067/mob.2002.127374

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Which parameters may influence the duration of hospitalization after vaginal hysterectomy?

Authors:  Abdulkadir Turgut; Hatice Ender Soydinç; Mehmet Sıddık Evsen; Serdar Başaranoğlu; Ahmet Yalınkaya
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

Review 2.  Uterine fibroid embolization: CME update for family physicians.

Authors:  Antony Raikhlin; Mark Otto Baerlocher; Murray R Asch
Journal:  Can Fam Physician       Date:  2007-02       Impact factor: 3.275

3.  [State and development of uterine myoma embolization in Germany].

Authors:  T F Jakobs; T K Helmberger; M F Reiser
Journal:  Radiologe       Date:  2003-08       Impact factor: 0.635

4.  Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada.

Authors:  Darrien D Rattray; Laura Weins; Lexy C Regush; James M Bowen; Daria O'Reilly; John A Thiel
Journal:  Clinicoecon Outcomes Res       Date:  2018-04-05

5.  Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids.

Authors:  H Zowall; J A Cairns; C Brewer; D L Lamping; W M W Gedroyc; L Regan
Journal:  BJOG       Date:  2008-04       Impact factor: 6.531

6.  Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs.

Authors:  Julia Malits; Mrudula Naidu; Leonardo Trasande
Journal:  Toxics       Date:  2022-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.